Event context and recent share performance Medline (MDLN) has come into focus after recent trading, with the share price last closing at $46. The stock shows modest positive returns over the past week ...
Being public gives the company a very attractive cost of capital currency to go and think creatively about what future deals ...
EQT makes a splash in the secondaries market in buying Coller Capital; a huge IPO deep dive involving Blackstone, Carlyle, ...
(In Jan 23 story, corrects deal value to $55 billion from $56.5 billion in paragraph 6) By Pritam Biswas and Arunima Kumar ...
Clorox said late Thursday it has agreed to buy GOJO Industries, the maker of Purell, for $2.25 billion in cash, in part ...
Goldman Sachs CEO David Solomon received a 20.5% pay raise to $47 million for 2025. This compensation package makes him one of Wall Street's top earners. The bank reported strong financial results ...
Goldman Sachs revealed that CEO David Solomons total annual compensation climbed 20.5% to $47 million for 2025, reflecting a ...
Improved dealmaking conditions drove a surge in investment banking fees for most of the top US banks in the final quarter of last year, as investors look ahead to what could be a milestone year for ...
Buzz60 on MSN
FDA orders immediate recall as cleaning chemicals infiltrate milk supply—2 states on alert
Prairie Farms Dairy has recalled 320 gallons of fat-free milk from 18 Woodman's Markets in Illinois and Wisconsin after ...
A surge in dealmaking and trading that helped cap a standout year for Goldman Sachs also delivered a sizable pay rise for its ...
Goldman Sachs announced on Friday that CEO David Solomon's total annual compensation rose 20.5% to $47 million for 2025, ...
Medline Inc. (NASDAQ:MDLN) is one of the stocks Jim Cramer recently looked at. Asking about the stock, a caller mentioned that they started their position when it was at $39. Cramer commented: I’m ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results